ASX:AVHAvita Medical Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Avita Medical Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add A$0.50 +0.04 (+8.70 %) (As of 05/13/2020) Add Compare Share Today's RangeA$0.45Now: A$0.50▼A$0.5150-Day RangeA$0.42MA: A$0.48▼A$0.5452-Week RangeA$0.33Now: A$0.50▼A$0.87Volume27.28 million shsAverage VolumeN/AMarket Capitalization$1.06 billionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsEarningsInsider TradesHeadlinesOptions Chain Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products for the treatment of burns, chronic wounds, and aesthetics indications. The company's patented and proprietary collection and application technology provides treatment solutions derived from a patient's own skin. Its lead product, RECELL System, is used in the treatment of various skin defects, such as burns and plastic reconstructive procedures. The company also offers ReGenerCell for chronic wounds and ReNovaCell for the restoration of pigmentation. Avita Medical Limited is based in Valencia, California.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Avita Medical. Previous Next 2.5 Community Rank Outperform VotesAvita Medical has received 14 “outperform” votes. (Add your “outperform” vote.)Underperform VotesAvita Medical has received 14 “underperform” votes. (Add your “underperform” vote.)Community SentimentAvita Medical has received 50.00% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Avita Medical and other stocks. Vote “Outperform” if you believe AVH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AVH will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldAvita Medical does not currently pay a dividend.Dividend GrowthAvita Medical does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Avita Medical insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Avita Medical is -250.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Avita Medical is -250.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAvita Medical has a P/B Ratio of 250.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.50 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolASX:AVH Previous Symbol CUSIPN/A CIKN/A Webwww.avitamedical.com Phone661-367-9170Debt Debt-to-Equity Ratio15.93 Current Ratio8.39 Quick Ratio8.35Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$495,188.00 Price / Sales2,138.05 Cash FlowA$0.01 per share Price / Cash Flow49.67 Book ValueA$0.00 per share Price / Book250.00Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees55 Outstanding Shares2,117,469,952Market Cap$1.06 billion Next Earnings DateN/A OptionableOptionable Receive AVH News and Ratings via Email Sign-up to receive the latest news and ratings for AVH and its competitors with MarketBeat's FREE daily newsletter. Avita Medical (ASX:AVH) Frequently Asked Questions How has Avita Medical's stock been impacted by COVID-19 (Coronavirus)? Avita Medical's stock was trading at A$0.47 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, AVH stock has increased by 6.4% and is now trading at A$0.50. View which stocks have been most impacted by Coronavirus. How were Avita Medical's earnings last quarter? Avita Medical Ltd (ASX:AVH) announced its quarterly earnings data on Thursday, February, 28th. The company reported ($0.02) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. View Avita Medical's earnings history. Has Avita Medical been receiving favorable news coverage? Press coverage about AVH stock has been trending somewhat positive recently, according to InfoTrie. The research firm identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Avita Medical earned a coverage optimism score of 1.5 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutAvita Medical. Who are some of Avita Medical's key competitors? Some companies that are related to Avita Medical include ConvaTec Group (CTEC), Stratec (SBS), Zynex (ZYXI), Draegerwerk AG & Co KGaA (DRW3), Avacta Group (AVCT), Creo Medical Group (CREO), Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB (IMR), Hamilton Thorne (HTL), Medica Group (MGP), Electromed (ELMD), Electromed (ELMD), Cyclopharm (CYC), Patient Home Monitoring (PTQ), Advanced Oncotherapy (AVO) and Somnomed (SOM). View all competitors. What other stocks do shareholders of Avita Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Avita Medical investors own include AVITA MED LTD/S (AVMXY), Audentes Therapeutics (BOLD), Northern Dynasty Minerals (NAK), Orchid Island Capital (ORC), Editas Medicine (EDIT), AVITA MED LTD/S (RCEL), Fortune Minerals (FT), Nemaska Lithium (NMX), Pfizer (PFE) and Stars Group (TSGI). Who are Avita Medical's key executives? Avita Medical's management team includes the following people: Dr. Michael S. Perry, CEO & Director (Age 60)Mr. Dale A. Sander, Chief Financial Officer (Age 59)Mr. Timothy Rooney, Chief Admin. OfficerMr. Andrew Quick, Sr. VP of Clinical Devel.Ms. Erin Liberto, Chief Commercial Officer What is Avita Medical's stock symbol? Avita Medical trades on the ASX under the ticker symbol "AVH." What is Avita Medical's stock price today? One share of AVH stock can currently be purchased for approximately A$0.50. How big of a company is Avita Medical? Avita Medical has a market capitalization of $1.06 billion and generates $495,188.00 in revenue each year. Avita Medical employs 55 workers across the globe. What is Avita Medical's official website? The official website for Avita Medical is www.avitamedical.com. How can I contact Avita Medical? The company can be reached via phone at 661-367-9170. This page was last updated on 5/25/2020 by MarketBeat.com Staff
